Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Frebourg

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Neurology|February 28, 2007
Variations in the APP gene promoter region and risk of Alzheimer diseaseL Guyant-Maréchal, A Rovelet-Lecrux, L Goumidi, et al.
British Journal of Cancer|April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapyA Oden-Gangloff, F Di Fiore, F Bibeau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1997
No effect of the alpha1-antichymotrypsin A allele in Alzheimer's diseaseO Didierjean, M Martinez, D Campion, et al.
Neuroreport|July 8, 1996
A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 yearsD Campion, A Brice, C Dumanchin, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
American Journal of Human Genetics|August 12, 1999
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrumD Campion, C Dumanchin, D Hannequin, et al.
Revue Neurologique|December 1, 1996
[Genetics of dominant autosomal forms of Alzheimer disease: 3 genes and one phenotype. Groupe de Recherche Francais sur la Maladie d'Alzheimer]A Brice, B Dubois, Y Agid, et al.
British Journal of Cancer|March 22, 2007
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapyF Di Fiore, F Blanchard, F Charbonnier, et al.
Annals of Human Genetics|January 31, 2006
Golli-MBP copy number analysis by FISH, QMPSF and MAPH in 195 patients with hypomyelinating leukodystrophiesC Vaurs-Barriere, M-N Bonnet-Dupeyron, P Combes, et al.
Journal of Medical Genetics|September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingE Domingo, P Laiho, M Ollikainen, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Neurology|February 28, 2007
Variations in the APP gene promoter region and risk of Alzheimer diseaseL Guyant-Maréchal, A Rovelet-Lecrux, L Goumidi, et al.
British Journal of Cancer|April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapyA Oden-Gangloff, F Di Fiore, F Bibeau, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1997
No effect of the alpha1-antichymotrypsin A allele in Alzheimer's diseaseO Didierjean, M Martinez, D Campion, et al.
Neuroreport|July 8, 1996
A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 yearsD Campion, A Brice, C Dumanchin, et al.
American Journal of Human Genetics|May 1, 1997
BRCA2 mutations in hereditary breast and ovarian cancer in FranceO M Serova-Sinilnikova, L Boutrand, D Stoppa-Lyonnet, et al.
American Journal of Human Genetics|August 12, 1999
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrumD Campion, C Dumanchin, D Hannequin, et al.
Revue Neurologique|December 1, 1996
[Genetics of dominant autosomal forms of Alzheimer disease: 3 genes and one phenotype. Groupe de Recherche Francais sur la Maladie d'Alzheimer]A Brice, B Dubois, Y Agid, et al.
British Journal of Cancer|March 22, 2007
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapyF Di Fiore, F Blanchard, F Charbonnier, et al.
Annals of Human Genetics|January 31, 2006
Golli-MBP copy number analysis by FISH, QMPSF and MAPH in 195 patients with hypomyelinating leukodystrophiesC Vaurs-Barriere, M-N Bonnet-Dupeyron, P Combes, et al.
Journal of Medical Genetics|September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingE Domingo, P Laiho, M Ollikainen, et al.
Pageof 11